Search Results

1 - 2 of 2 items :

  • "encapsulation" x
  • Emergency Medicine and Intensive-Care Medicine x
Clear All
Inflammation in Acute Cardiac Care

- Inducible Factor 1-Alpha Release After Intracoronary Versus Intramyocardial Stem Cell Therapy in Myocardial Infarction. J Cardiovasc Transl Res. 2010;3:114-121. doi: 10.1007/s12265-009-9154-1. 15. Lazar E, Benedek T, Korodi Sz, et al. Stem cell-derived exosomes - an emerging tool for myocardial regeneration. World J Stem Cells. 2018;10:106-115. doi: 10.4252/wjsc.v10.i8.106. 16. Tang J, Cui X, Caranasos TG, et al. Heart Repair Using Nanogel- Encapsulated Human Cardiac Stem Cells in Mice and Pigs with Myocardial Infarction. ACS Nano. 2017

Open access
Fading Sugammadex, or Just Cautiously (re) Considered?!

References 1. Booj LHDJ, De Boer HD, Van Egmond J. Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept. Semin Anesth Periop Med Pain. 2002; 21:92-98. 2. Bom A, Bradley M, Cameron K, Clark JK, Van Egmond J, Feilden H, Mac Lean EJ, Muir AW, Palin R, Rees DC, Zhang M-Q. A novel concept of reversing neuromuscular block: Chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. Angew Chem Int Ed Engl. 2002; 41:266-270. 3. De Boer HD, van

Open access